Cargando…
Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
PURPOSE: Most patients with early-stage breast cancer are treated with adjuvant radiotherapy (RT) after breast-conserving surgery (BCS) to prevent locoregional recurrence (LRR). However, no genomic tools are used currently to select the optimal RT strategy. METHODS: We profiled the transcriptome of...
Autores principales: | Sjöström, Martin, Chang, S. Laura, Fishbane, Nick, Davicioni, Elai, Zhao, Shuang G., Hartman, Linda, Holmberg, Erik, Feng, Felix Y., Speers, Corey W., Pierce, Lori J., Malmström, Per, Fernö, Mårten, Karlsson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901281/ https://www.ncbi.nlm.nih.gov/pubmed/31618132 http://dx.doi.org/10.1200/JCO.19.00761 |
Ejemplares similares
-
Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
por: Sjöström, Martin, et al.
Publicado: (2023) -
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast‐conserving surgery: a long‐term follow‐up of the SweBCG91‐RT randomised trial
por: Sjöström, Martin, et al.
Publicado: (2020) -
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up
por: Tutzauer, Julia, et al.
Publicado: (2022) -
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial
por: Strell, Carina, et al.
Publicado: (2021) -
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
por: Sjöström, Martin, et al.
Publicado: (2018)